Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

983 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized phase I clinical trial of anti-α-synuclein antibody BIIB054.
Brys M, Fanning L, Hung S, Ellenbogen A, Penner N, Yang M, Welch M, Koenig E, David E, Fox T, Makh S, Aldred J, Goodman I, Pepinsky B, Liu Y, Graham D, Weihofen A, Cedarbaum JM. Brys M, et al. Among authors: fox t. Mov Disord. 2019 Aug;34(8):1154-1163. doi: 10.1002/mds.27738. Epub 2019 Jun 17. Mov Disord. 2019. PMID: 31211448 Free PMC article. Clinical Trial.
Trial of Cinpanemab in Early Parkinson's Disease.
Lang AE, Siderowf AD, Macklin EA, Poewe W, Brooks DJ, Fernandez HH, Rascol O, Giladi N, Stocchi F, Tanner CM, Postuma RB, Simon DK, Tolosa E, Mollenhauer B, Cedarbaum JM, Fraser K, Xiao J, Evans KC, Graham DL, Sapir I, Inra J, Hutchison RM, Yang M, Fox T, Budd Haeberlein S, Dam T; SPARK Investigators. Lang AE, et al. Among authors: fox t. N Engl J Med. 2022 Aug 4;387(5):408-420. doi: 10.1056/NEJMoa2203395. N Engl J Med. 2022. PMID: 35921450 Clinical Trial.
Cinpanemab in Early Parkinson Disease: Evaluation of Biomarker Results From the Phase 2 SPARK Clinical Trial.
Hutchison RM, Fraser K, Yang M, Fox T, Hirschhorn E, Njingti E, Scott D, Bedell BJ, Kistner KM, Cedarbaum JM, Evans KC, Graham D, Martarello L, Mollenhauer B, Lang AE, Dam T, Beaver J. Hutchison RM, et al. Among authors: fox t. Neurology. 2024 Mar 12;102(5):e209137. doi: 10.1212/WNL.0000000000209137. Epub 2024 Feb 5. Neurology. 2024. PMID: 38315945 Clinical Trial.
A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naïve metastatic/unresectable non-small cell lung cancer.
Reck M, Krzakowski M, Chmielowska E, Sebastian M, Hadler D, Fox T, Wang Q, Greenberg J, Beckman RA, von Pawel J. Reck M, et al. Among authors: fox t. Lung Cancer. 2013 Dec;82(3):441-8. doi: 10.1016/j.lungcan.2013.09.014. Epub 2013 Oct 1. Lung Cancer. 2013. PMID: 24148258 Clinical Trial.
Proximal-muscle weakness induced by herbs.
Capobianco DJ, Brazis PW, Fox TP. Capobianco DJ, et al. Among authors: fox tp. N Engl J Med. 1993 Nov 4;329(19):1430. doi: 10.1056/NEJM199311043291919. N Engl J Med. 1993. PMID: 8413452 No abstract available.
Improving access to gene therapy for rare diseases.
Fox TA, Booth C. Fox TA, et al. Dis Model Mech. 2024 Jun 1;17(6):dmm050623. doi: 10.1242/dmm.050623. Epub 2024 Apr 19. Dis Model Mech. 2024. PMID: 38639083 Free PMC article.
A pilot randomised controlled trial exploring the feasibility and efficacy of a human-AI sleep coaching model for improving sleep among university students.
Liu J, Ito S, Ngo TM, Lawate A, Ong QC, Fox TE, Chang SY, Phung D, Nair E, Palaiyan M, Joty S, Abisheganaden J, Lee CP, Lwin MO, Theng YL, Ho MR, Chia M, Bojic I, Car J. Liu J, et al. Among authors: fox te. Digit Health. 2024 Apr 17;10:20552076241241244. doi: 10.1177/20552076241241244. eCollection 2024 Jan-Dec. Digit Health. 2024. PMID: 38638406 Free PMC article.
Wolbachia-carrying Aedes mosquitoes for preventing dengue infection.
Fox T, Sguassero Y, Chaplin M, Rose W, Doum D, Arevalo-Rodriguez I, Villanueva G. Fox T, et al. Cochrane Database Syst Rev. 2024 Apr 10;4(4):CD015636. doi: 10.1002/14651858.CD015636.pub2. Cochrane Database Syst Rev. 2024. PMID: 38597256 Free PMC article. Review.
983 results